Inovio Pharma
(INO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 03-2001 | |
| Sales | 1,167 | 81 | 190 | 0 | 4,291 |
| Gross Profit | 1,167 | 81 | 190 | N/A | 4,291 |
| Operating Expenses | 12,678 | 6,714 | 6,124 | 0 | 9,584 |
| Operating Income | -11,511 | -6,633 | -5,935 | N/A | -5,292 |
| Interest Expense | 0 | 21 | 5 | 0 | 20 |
| Other Income | 248 | 66 | 32 | 0 | 377 |
| Pre-tax Income | -11,263 | -6,588 | -5,908 | 0 | -4,936 |
| Net Income Continuous | -11,263 | -6,588 | -5,908 | N/A | -4,936 |
| Net Income Discontinuous | 290 | 1,923 | -57 | N/A | -284 |
| Net Income | $-10,973 | $-4,665 | $-5,965 | $N/A | $-8,866 |
| EPS Basic Total Ops | -31.69 | -16.81 | -28.33 | N/A | -61.46 |
| EPS Basic Continuous Ops | -30.73 | -23.53 | -27.85 | N/A | -34.57 |
| EPS Basic Discontinuous Ops | 0.96 | 6.72 | -0.48 | N/A | -1.92 |
| EPS Diluted Total Ops | -31.69 | -16.81 | -28.33 | N/A | -61.46 |
| EPS Diluted Continuous Ops | -30.73 | -23.53 | -27.85 | N/A | -34.57 |
| EPS Diluted Discontinuous Ops | 0.96 | 6.72 | -0.48 | N/A | -1.92 |
| EBITDA(a) | $-10,938 | $-6,049 | $-5,316 | $N/A | $-4,669 |